This is a news story, published by Washington University School of Medicine in St. Louis, that relates primarily to Ruminococcus news.
For more biology news, you can click here:
more biology newsFor more news from Washington University School of Medicine in St. Louis, you can click here:
more news from Washington University School of Medicine in St. LouisOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about
gut microbes. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest gut bacteria news, microbiome news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
gut microbiotaWashington University School of Medicine in St. Louis
•86% Informative
A strain of gut bacteria Ruminococcus gnavus can enhance the effects of cancer immunotherapy.
Study suggests a new strategy of using gut microbes to help unlock immunotherapy’s untapped cancer-fighting potential.
Identifying relevant species could lead to a next-generation probiotic that could synergize with immunotherapy to improve cancer care.
VR Score
90
Informative language
93
Neutral language
28
Article tone
formal
Language
English
Language complexity
71
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
5
Source diversity
2
Affiliate links
no affiliate links